Effects of Tumor Burden Reduction on Survival in Epithelioid Pleural Mesothelioma

被引：0
作者：
Mansfield, A. [1 ]
Peikert, T. [2 ]
Vogelzang, N. [3 ]
Symanowski, J. [4 ]
机构：
[1] Mayo Clin, Med Oncol, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
[3] Comprehens Canc Ctr Nevada, Us Oncol Res, Las Vegas, NV USA
[4] Carolinas Healthcare Syst, Levine Canc Inst, Dept Canc Biostat, Charlotte, NC USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
mesothelioma; response; survival;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.09-001
引用
收藏
页码：S2155 / S2156
页数：2
相关论文
共 50 条
  • [41] Thoracoscopic Assessment of Pleural Tumor Burden in Patients with Malignant Pleural Effusion Prognostic and Therapeutic Implications
    Sakr, Lama
    Maldonado, Fabien
    Greillier, Laurent
    Dutau, Herve
    Loundou, Anderson
    Astoul, Philippe
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : 592 - 597
  • [42] Mortality Based on Treatment in Stage III Non-Epithelioid Pleural and Pericardial Mesothelioma - A Review from a National Cohort
    Zweigle, J. W.
    Mohamed, R.
    Batoo, S. A.
    Qadir, M.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S688 - S688
  • [43] Assessment of interferon-γ in pleural fluid as a prognostic factor of survival in malignant pleural mesothelioma
    Beatrice Dozin
    Grazia Carbotti
    Silvio Roncella
    Paola Ferro
    Paolo Dessanti
    Pier Aldo Canessa
    Silvano Ferrini
    Marina Fabbi
    Cancer Immunology, Immunotherapy, 2021, 70 : 3349 - 3355
  • [44] Effects of combined therapies on the survival of pleural mesothelioma patients treated in Brescia, 1982-2006
    Barbieri, Pietro Gino
    Marinaccio, Alessandro
    Ferrante, Pierpaolo
    Scarselli, Alberto
    Pinelli, Valentina
    Tassi, Gianfranco
    TUMORI JOURNAL, 2012, 98 (02): : 215 - 219
  • [45] Survival of malignant pleural mesothelioma cases in the Tuscan Mesothelioma Register, 1988-2000: a population-based study
    Gorini, G
    De Gregori, G
    Silvestri, S
    Chellini, E
    Cupelli, V
    Costantini, AS
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2005, 14 (03) : 195 - 199
  • [46] Assessment of interferon-γ in pleural fluid as a prognostic factor of survival in malignant pleural mesothelioma
    Dozin, Beatrice
    Carbotti, Grazia
    Roncella, Silvio
    Ferro, Paola
    Dessanti, Paolo
    Canessa, Pier Aldo
    Ferrini, Silvano
    Fabbi, Marina
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (11) : 3349 - 3355
  • [47] Survival after conservative (palliative) management of pleural malignant mesothelioma
    Merritt, N
    Blewett, C
    Miller, JD
    Bennett, WF
    Young, JEM
    Urschel, JD
    JOURNAL OF SURGICAL ONCOLOGY, 2001, 78 (03) : 171 - 174
  • [48] A novel prognostic nomogram for predicting survival in diffuse pleural mesothelioma
    Aksoy, Yagiz
    Chou, Angela
    Mahjoub, Mahiar
    Sheen, Amy
    Sioson, Loretta
    Ahadi, Mahsa S.
    Gill, Anthony J.
    Fuchs, Talia L.
    PATHOLOGY, 2023, 55 (04) : 449 - 455
  • [49] Histopathological features of epithelioid malignant pleural mesotheliomas in patients with extended survival
    Paajanen, Juuso
    Laaksonen, Sanna
    Kettunen, Eeva
    Ilonen, Ilkka
    Vehmas, Tapio
    Salo, Jarmo
    Rasanen, Jari
    Sutinen, Eva
    Ollila, Hely
    Mayranpaa, Mikko, I
    Myllarniemi, Marjukka
    Wolff, Henrik
    HUMAN PATHOLOGY, 2020, 98 : 110 - 119
  • [50] Basic fibroblast growth factor in mesothelioma pleural effusions: Correlation with patient survival and angiogenesis
    Strizzi, L
    Vianale, G
    Catalano, A
    Muraro, R
    Mutti, L
    Procopio, A
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 18 (05) : 1093 - 1098
12345